Abstract

181P Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract B047: Tertiary lymphoid structures and B cells signatures determine clinically relevant T cell phenotype in ovarian cancer
Lenka Kasikova ... Irena Kusova Moserova
Cancer Immunology Research | VOL. 11
Lenka Kasikova, et. al.Lenka Kasikova ... Irena Kusova Moserova
01 Dec 2023
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Alice Taskova ... Sandra Orsulic
Nature Communications | VOL. 15
Alice Taskova, et. al.Alice Taskova ... Sandra Orsulic
21 Mar 2024
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.
Xue Han ... Hongluan Mao
Frontiers in genetics | VOL. 13
Xue Han, et. al.Xue Han ... Hongluan Mao
10 Jan 2023
Abstract 1021: Clinical significance of tertiary lymphoid structures (TLS) and tumor-infiltrating plasma cells in ovarian cancer
Masayo Ukita ... Kaoru Abiko
Cancer Research | VOL. 78
Masayo Ukita, et. al.Masayo Ukita ... Kaoru Abiko
01 Jul 2018
View more papers

More From: Immuno-Oncology and Technology

Paper Title
Journal
Date
Author
Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy – a retrospective and biomarker study
Fernanda Costa Svedman ... Suzanne Egyhazi Brage
Immuno-Oncology and Technology | VOL. -
Fernanda Costa Svedman, et. al.Fernanda Costa Svedman ... Suzanne Egyhazi Brage
01 May 2024
Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
Caroline Dive ... Kirellos S Abbas
Immuno-Oncology and Technology | VOL. 22
Caroline Dive, et. al.Caroline Dive ... Kirellos S Abbas
18 Mar 2024
Table of Contents
-
Immuno-Oncology and Technology | VOL. 21
--
01 Mar 2024
Editorial Board
-
Immuno-Oncology and Technology | VOL. 21
--
01 Mar 2024
View more papers